Risk advoidance
LIFE has been tough for insurance brokers. One of the world's biggest, Alexander & Alexander, was struggling for survival when Aon, a Chicago-based fellow giant, rescued it in December. On March 12th the industry was turned upside down once more when second-ranking Marsh & McLennan agreed to buy one of its biggest competitors, Johnson & Higgins. The $1.8 billion deal will create a firm whose combined revenues last year were $5.3 billion. Whether it will make the core business worthwhile is a different question.
More from Finance & economics
China meets its official growth target. Not everyone is convinced
For one thing, 2024 saw the second-weakest rise in nominal GDP since the 1970s
Ethiopia gets a stockmarket. Now it just needs some firms to list
The country is no longer the most populous without a bourse
Are big cities overrated?
New economic research suggests so
Why catastrophe bonds are failing to cover disaster damage
The innovative form of insurance is reaching its limits
“The Traitors”, a reality TV show, offers a useful economics lesson
It is a finite, sequential, incomplete information game
Will Donald Trump unleash Wall Street?
Bankers have plenty of reason to be hopeful